The prognostic value of baseline 18F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 43, Issue 2, 2016, Pages 340-348

  Dellavedova, L ^a,b   Carletto, M ^a   Faggioli, P ^a   Sciascera, A ^a   Del Sole, A ^b   Mazzone, A ^a   Maffioli, L S ^a  

^a Ospedale Civile di Legnano   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

18F FDG PET CT; Large vessel vasculitis; Prognosis; Volume based parameters

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; PREDNISONE; CORTICOSTEROID; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGING SOFTWARE; LARGE VESSEL VASCULITIS; MALE; MIDDLE AGED; PET-CT SCANNER; PILOT STUDY; PROGNOSIS; PYREXIA IDIOPATHICA; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THICKNESS; TOTAL LESION GLYCOLYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS; VERY ELDERLY; VOLUME OF INCREASED UPTAKE; ARTERITIS; DIAGNOSTIC IMAGING; EVALUATION STUDY; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

ADRENAL CORTEX HORMONES; AGED; ARTERITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84952986744     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-015-3148-9     Document Type: Article

References (43)

1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37(2):187–92.
2. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65(1):1–11.
3. Balink H, Bennink RJ, van Eck-Smit BLF, et al. The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? Biomed Res Int 2014;2014:687608.
4. Muratore F, Kermani TA, Crowson CS, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford) 2015;54(3):463–70.
5. Germanò G, Muratore F, Cimino L, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology (Oxford) 2015;54(3):400–4.
6. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372(9634):234–45.
7. Katsuyama T, Sada KE, Makino H. Current concept and epidemiology of systemic vasculitides. Allergol Int 2014;63:505–13.
8. Prieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol 2015;27(1):53–62.
9. Belhocine T, Blockmans D, Hustinx R, et al. Imaging of large vessel vasculitis with 18F-FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003;30:1305–13.
10. Glaudemans AWJM, de Vries EFJ, Galli F, et al. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013;2013:623036.
11. Santhosh S, Mittal BR, Gayana S, et al. 18F-FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol 2014;21:993–1000.
12. Prieto-Gonzáles S, Depetris M, Garcia-Martinez A, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study. Ann Rheum Dis 2014;73(7):1388–92.
13. Osborn EA, Jaffer FA. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging 2013;6(12):1327–41.
14. Papathanasiou ND, Du Y, Menezes LJ, et al. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol 2012;85(1014):e188–94.
15. Sanchez-Roa P, Rees J, Nash J, et al. FDG PET in the early diagnosis of large-vessel vasculitis. Eur J Nucl Med Mol Imaging 2013;40:974–5.
16. Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 2012;5(4):422–9.
17. Zerizer I, Tan K, Khan S, et al. Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol 2010;73(3):504–9.
18. Muto G, Yamashita H, Takahashi Y, et al. Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT. Rheumatol Int 2014;34(11):1545–54.
19. Rozzanigo U, Pellegrin A, Centonze M, et al. Diagnosis of large-vessel vasculitis using [18F]-FDG PET-CT. Radiol Med 2013;118:633–47.
20. Jamar F, Buscombe J, Chiti A, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 2013;54(4):647–58.
21. Hautzel H, Sander O, Heinzel A, et al. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis–based cutoff ratio. J Nucl Med 2008;49:1107–13.
22. Martínez-Rodríguez I, Del Castillo-Matos R, Quirce R, et al. Aortic 18F-FDG PET/CT uptake pattern at 60 min (early) and 180 min (delayed) acquisition in a control population: a visual and semiquantitative comparative analysis. Nucl Med Commun 2013;34(9):926–30.
23. Martínez-Rodríguez I, Martínez-Amador N, Banzo I, et al. Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition images. Eur J Nucl Med Mol Imaging 2014;41(12):2319–24.
24. Besson FL, de Boysson H, Parienti JJ, et al. Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case–control study. Eur J Nucl Med Mol Imaging 2014;41:155–66.
25. Puppo C, Massello M, Paparo F, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. Biomed Res Int 2014;2014:574248.
26. Blockmans D, de Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55(1):131–7.
27. Figueroa AL, Abdelbaky A, Truong QA, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging 2013;6(12):1250–9.
28. Blockmans D, Bley T, Schmidt W. Imaging of large-vessel vasculitis. Curr Opin Rheumatol 2009;21:19–28.
29. Biggi A, Burroni L, Carena M, et al. Raccomandazioni procedurali per lo studio delle infezioni-infiammazioni. AIMN, 2011. Available via http://www.aimn.it/pubblicazioni/LG/RP_AIMN_infezioni.pdf.
30. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]-FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30(5):730–6.
31. Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 2014;371(1):50–7.
32. Maffioli L, Mazzone A. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 2014;371(17):1652–3.
33. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009;68:318–23.
34. Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2(3):159–71.
35. Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999;38(5):444–7.
36. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 1999;23(1):16–8.
37. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990;33(8):1065–7.
38. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33(8):1122–8.
39. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–34.
40. Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008;47(8):1179–84.
41. Bai B, Bading J, Conti PS. Tumor quantification in clinical positron emission tomography. Theranostics 2013;3(10):787–801.
42. Kim TM, Paeng JC, Chun IK, et al. Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma. Cancer 2013;119(6):1195–202.
43. Moon SH, Hyun SH, Choi JY. Prognostic significance of volume-based PET parameters in cancer patients. Korean J Radiol 2013;14(1):1–12.